Consort Medical plc (LON:CSRT)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 1,224 ($16.60) and last traded at GBX 1,203 ($16.31), with a volume of 3390 shares trading hands. The stock had previously closed at GBX 1,174 ($15.92).
Several equities analysts recently issued reports on CSRT shares. Stifel Nicolaus reiterated a “buy” rating and set a GBX 1,250 ($16.95) price target on shares of Consort Medical in a research report on Thursday, November 9th. Numis Securities boosted their price target on shares of Consort Medical from GBX 1,084 ($14.70) to GBX 1,144 ($15.51) and gave the company a “hold” rating in a research report on Wednesday, December 6th. Shore Capital reiterated a “buy” rating on shares of Consort Medical in a research report on Tuesday, December 5th. Finally, N+1 Singer cut shares of Consort Medical to a “hold” rating in a research report on Tuesday, December 5th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of GBX 1,188.17 ($16.11).
The firm has a market capitalization of $585.97 and a price-to-earnings ratio of 2,972.55.
The firm also recently disclosed a dividend, which will be paid on Friday, February 16th. Shareholders of record on Thursday, January 18th will be issued a GBX 7.44 ($0.10) dividend. This represents a yield of 0.66%. The ex-dividend date is Thursday, January 18th.
ILLEGAL ACTIVITY NOTICE: This news story was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/01/15/consort-medical-csrt-reaches-new-12-month-high-at-1224-00.html.
About Consort Medical
Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.
Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with MarketBeat.com's FREE daily email newsletter.